Shanghai Bojin Biotechnology

Shanghai Bojin Biotechnology is a private Chinese biotechnology company based in Shanghai and founded in 2017. Publicly accessible company registry and drug-intelligence sources indicate it is active and operates in biotechnology, with available evidence pointing to early-stage anticoagulation R&D focused on antibodies against coagulation factor XI and activated factor XIa. The company appears to be part of the broader Bojia/Boyu biopharma corporate group and is identified as a subsidiary in third-party biopharma databases. No validated evidence of clinical-stage assets, marketed products, or public listing was found in accessible sources, so the company appears to remain at an early preclinical or discovery stage.